FDA Alert: Legacy Pharmaceutical Recalls More Losartan Tablets

FDA Alert: Legacy Pharmaceutical Recalls More Losartan Tablets
Jack Phillips
Jack Phillips
Breaking News Reporter
|Updated:

Legacy Pharmaceutical Packaging said it’s recalling 40 lots of Losartan Tablets, which are used to treat heart failure and high blood pressure.

According to a notice posted on the U.S. Food and Drug Administration (FDA) website, the recall was prompted due after “trace amounts of N-Nitroso N-Methyl 4-amino butyric acid (NMBA),” which is potentially carcinogenic, was found. It was also triggered due to Camber Pharmaceuticals issuing a voluntary recall of the same medication, manufactured by Hetero Labs in India.

Jack Phillips
Jack Phillips
Breaking News Reporter
Jack Phillips is a breaking news reporter who covers a range of topics, including politics, U.S., and health news. A father of two, Jack grew up in California's Central Valley. Follow him on X: https://twitter.com/jackphillips5
twitter
Related Topics